Delivery Order SPE2DR25D1100-SPE2DR26FCM9F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 per unit, with a ceiling value of $12,891.33. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $13,765.22. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The order is set for ultimate completion on November 6, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, with a contract ceiling value of $20,190.18. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $23,354.50 and an ultimate completion date of September 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-competitive delivery order, valued at $13,063.67 with firm fixed pricing, represents a pharmaceutical procurement under the agency's medical supply chain operations. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters, and...
- The Defense Logistics Agency awarded a $44,543.69 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units, valued at $3,568.75. This is a firm fixed-price delivery order with no set-aside designation, reflecting open competitive procurement. The order is scheduled for completion by October 22, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 tablets, with a ceiling value of $2,915.55. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $13,626.03 and an ultimate completion date of October 17, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $12,635.04 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets (30-count units) on October 31, 2025, with completion scheduled for November 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered to the...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCM9FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,728.49 and is scheduled for completion by November 6, 2025. The delivery order is structured as a firm fixed-price contract, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999 million through December 2026. This prime vehicle enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and has demonstrated capability to fulfill federal supply requirements through open competition across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/5/25 |